Navigation Links
Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
Date:10/29/2007

ients with Ph+ CML.

Tasigna was specifically designed to target the Bcr-Abl protein more preferentially than Gleevec without adding new targets. At six months follow-up, Tasigna reduced or eliminated cells carrying the abnormal Philadelphia chromosome in 40% of patients in chronic phase of the disease.

Applying experience gained from the development of Gleevec, which remains the most frequently prescribed treatment for patients with Ph+ CML, a team of Novartis scientists created Tasigna in August 2002, just a year after the launch of Gleevec. In preclinical studies, the medicine was able to overcome resistance resulting from Bcr-Abl kinase mutations in 32 of 33 cell lines commonly associated with Ph+ CML. Patients with a variety of these mutations also responded to treatment with Tasigna.

The first worldwide approval for Tasigna came in Switzerland in July 2007. European Union approval is expected by the end of this year after the Committee for Medicinal Products for Human Use (CHMP), which reviews medicines in Europe, issued a positive opinion in September. Tasigna was also submitted for approval in Japan in June.

Without treatment, CML typically progresses over three to five years from the initial (chronic) phase through a transition period (accelerated phase) to a rapidly fatal form (blast crisis)(2). Recent landmark clinical trial results for Gleevec show that nearly 90% of newly diagnosed chronic-phase Ph+ CML adult patients treated with Gleevec were alive after five years(3), but some develop resistance or cannot tolerate this therapy.

The FDA approved Tasigna for treatment of chronic-phase and accelerated- phase Ph+ CML in adult patients resistant or intolerant to prior treatment that included Gleevec. This approval is based on an open-label multicenter clinical trial evaluating the drug's safety and rates of cytogenetic response (i.e. reduction or elimination of the Philadelphia chromosome) and hematologic response (i.e. normali
'/>"/>

SOURCE Novartis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cut down TV and video games and you have less aggressive children.
2. Parents Should Beware of Violent Video Games
3. Children’s obesity linked to video game
4. Poland: Parental warning systems are likely to be adopted in video games.
5. Video Games, The Latest Craze Of American Adults
6. Interactive Video, Better Teaching Aid For Toddlers
7. Video Games Reduces Surgical Errors – A Stud
8. Fun And Cure With Video Games
9. Stroke Rehabilitation Through Modified Video Games
10. Videoconferencing, an impetus to Pediatric Oncology
11. Free Online Educational Videos for People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 01, 2014 As AndroGel lawsuits and ... Ronald E. Johnson, Jr. has been appointed as co-lead ... other testosterone medications. Since the Fall of 2013, Ron ... worked diligently to investigate and prosecute the claims of ... blood clots as a result of taking testosterone. As ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Growing ... coverage and healthcare reforms are boosting healthcare market ... medicines through discounts and increasing generic consumption is ... approximately 76.7 million in 2013, having grown at ... from 2008. The implementation of the Health Transformation ...
(Date:8/1/2014)... The "Antimicrobial Coatings Market by Type (Silver, Copper, ... and Zinc Omadine), Application (Indoor air/HVAC, Medical, Mold ... and others), & Geography (North America, Europe, Asia-Pacific, ... 2018" analyzes the Antimicrobial Coatings Market with respect ... diverse geographical regions. , Browse 49 market data ...
(Date:8/1/2014)... According to new market research report "Automotive ... Europe, & ROW), by Vehicle Type (Passenger Cars, ... Diesel), by After-Treatment Device (DPF, DOC, SCR, TWC, ... 2019", defines and segments the global automotive exhaust ... in all the regions, and estimates their exhaust ...
(Date:8/1/2014)... August 1, 2014 The Cardiovascular Research ... first report investigations that will be presented at ... symposium. TCT, the world,s premier educational meeting specializing ... 13 17, 2014 at the Walter E. ... research data presented at TCT often direct the ...
Breaking Medicine News(10 mins):Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4
... , , , WASHINGTON, Aug. ... of the health community in mourning the loss of Senator Edward ... causes, particularly the medically underserved. His work in advancing medical innovation ... America,s ability to invest in cures for illnesses that affect patients ...
... , WEDNESDAY, Aug. 26 (HealthDay News) -- Two new European ... use for diagnosing possible heart attacks in emergency room patients, ... 27 issue of the New England Journal of Medicine ... damaged heart cells. Standard practice in most hospitals now calls ...
... the growth of human colon cancer cells, preventing the disease ... The research, published today in EMBO Molecular Medicine , ... growth of tumours, metastatic lesions and cancer stem cells, the ... Colon cancer often begins in a treatable form when ...
... , , NASHVILLE, Tenn., Aug. ... for the Community" campaign as Nashville Mayor Karl Dean, HCA CEO ... attended the 2009 kickoff event for the corporate office,s employee giving ... (Logo: http://www.ne w s com.com/cgi-bin/prnh/20050825/CLTH069LOGO ...
... , , , ... Health Record Association (EHR Association) responded with enthusiasm to the ... nearly $1.2 billion to help hospitals and health care providers ... of the continued implementation of the healthcare IT provisions of ...
... ... Generation and Gender Impact Physician Engagement", , ... Charlotte, NC (Vocus) August 26, 2009 -- Morehead , the human capital ... Engagement." The free hour-long webinar will be broadcast on Wednesday, September 16, 2009 at ...
Cached Medicine News:Health News:Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy 2Health News:Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy 3Health News:Newer, Better Tests for Heart Attacks 2Health News:Newer, Better Tests for Heart Attacks 3Health News:'Hedgehog' pathway may hold key to anti-cancer therapy 2Health News:HCA Kicks Off 2009 'Caring for the Community' Campaign 2Health News:HIMSS Electronic Health Record Association Applauds Federal Support of EHR Implementation for Hospitals and Physician Practices 2Health News:HIMSS Electronic Health Record Association Applauds Federal Support of EHR Implementation for Hospitals and Physician Practices 3Health News:Morehead Presents Webinar on 'He Said…She Said: How Gender Differences Impact Physician Engagement' 2
(Date:8/1/2014)... -- In the latest call for gender equity in ... 60 doctors and leading medical experts from across the ... and Drug Administration,s (FDA) decision to approve 26 drugs ... dysfunction compared with ZERO for women,s most common complaint, ... by approving the first-ever drug to treat Hypoactive Sexual ...
(Date:8/1/2014)... , August 1, 2014 ... Market by Type (Traditional Wound Closure, Anti infective), Basic ... (Artificial Skin & Skin Substitutes), Pressure Relief Devices, ... MarketsandMarkets, the global Wound Care Market is expected to ... in 2014, growing at a CAGR of 3.2% ...
(Date:8/1/2014)... PLYMOUTH MEETING, Pa. , Aug. 1, 2014 /PRNewswire/ ... that it will host a conference call to report ... 11, 2014 at 9:00 AM ET. CEO Dr. ... will discuss second quarter earnings, provide a corporate ... The update will include clinical development plans for VGX-3100, ...
Breaking Medicine Technology:60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3
... EAU study conducted with University of Pennsylvania shows ... different approaches,are being used to increase milk production ... at the University of Pennsylvania School of,Veterinary Medicine ... technology created by EAU Technologies, has the potential ...
... study to commence late this year, ... (ASX:,CYT) has selected CYT387, a selective and ... treat myeloproliferative disorders (MPDs). This,follows extensive laboratory ... in an in-vivo model of myeloproliferative,disease., ...
Cached Medicine Technology:Increasing Dairy Milk Production with Electrolyzed Drinking Water 2Increasing Dairy Milk Production with Electrolyzed Drinking Water 3Increasing Dairy Milk Production with Electrolyzed Drinking Water 4Increasing Dairy Milk Production with Electrolyzed Drinking Water 5Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders 2Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: